These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6824635)

  • 21. Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.
    Agarwal RP; Spector T; Parks RE
    Biochem Pharmacol; 1977 Mar; 26(5):359-67. PubMed ID: 849330
    [No Abstract]   [Full Text] [Related]  

  • 22. Structure of bovine adenosine deaminase complexed with 6-hydroxy-1,6-dihydropurine riboside.
    Kinoshita T; Nishio N; Nakanishi I; Sato A; Fujii T
    Acta Crystallogr D Biol Crystallogr; 2003 Feb; 59(Pt 2):299-303. PubMed ID: 12554940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assignment of downfield proton resonances in an enzyme inhibitor complex using time-dependent saturation transferred NOEs.
    Deng H; Cahill S; Kurz L; Callender R
    J Am Chem Soc; 2004 Feb; 126(7):1952-3. PubMed ID: 14971925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependency of adenosine deaminase and purine nucleoside phosphorylase activities in rat spleen and thymus.
    Peters GJ; Oosterhof A; Veerkamp JH
    Biol Neonate; 1982; 42(3-4):195-200. PubMed ID: 6814540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase and immunodeficiency: an in vitro model.
    Hirschhorn R; Sela E
    Cell Immunol; 1977 Aug; 32(2):350-60. PubMed ID: 902324
    [No Abstract]   [Full Text] [Related]  

  • 26. Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
    Hall JG; Gyure L; Peppard J; Orlans E
    Br J Cancer; 1979 Nov; 40(5):750-4. PubMed ID: 508578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypersensitivity of an enzyme reaction to solvent water.
    Dzingeleski GD; Wolfenden R
    Biochemistry; 1993 Sep; 32(35):9143-7. PubMed ID: 8369284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purine deoxyribonucleoside induced hepatotoxicity in the mouse.
    Renshaw J; Paine RM; Taylor GA; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():363-6. PubMed ID: 6609540
    [No Abstract]   [Full Text] [Related]  

  • 29. Hexofuranosyladenine nucleosides as substrates and inhibitors of calf intestinal adenosine deaminase.
    Grant AJ; Lerner LM
    J Med Chem; 1979 Aug; 22(8):1016-8. PubMed ID: 490534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine deaminase (E.C. 3.5.4.4) from Hymenolepis diminuta.
    Gamble HR; Pappas PW
    J Parasitol; 1981 Oct; 67(5):759-60. PubMed ID: 6795332
    [No Abstract]   [Full Text] [Related]  

  • 31. Site-directed mutagenesis of active site glutamate-217 in mouse adenosine deaminase.
    Mohamedali KA; Kurz LC; Rudolph FB
    Biochemistry; 1996 Feb; 35(5):1672-80. PubMed ID: 8634299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic synthesis of purine 2'-deoxyriboside and its properties as an inhibitor of adenosine deaminases from calf intestinal mucosa and Bacillus cereus.
    Caffaz S; Allegrini S; Cercignani G
    Ital J Biochem; 1990; 39(2):115-20. PubMed ID: 2113897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of racemic carbocyclic analogues of purine nucleosides through the action of adenosine deaminase. Antiviral activity of the carbocyclic 2'-deoxyguanosine enantiomers.
    Secrist JA; Montgomery JA; Shealy YF; O'Dell CA; Clayton SJ
    J Med Chem; 1987 Apr; 30(4):746-9. PubMed ID: 3031295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine deaminase covalently linked to soluble dextran. The effect of immobilization on thermodynamic and kinetic parameters.
    Rosemeyer H; Körnig E; Seela F
    Eur J Biochem; 1982 Feb; 122(2):375-80. PubMed ID: 6174333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of substituent ribose on transition state affinity in reactions catalyzed by adenosine deaminase.
    Wolfenden R; Wentworth DF; Mitchell GN
    Biochemistry; 1977 Nov; 16(23):5071-7. PubMed ID: 562185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations.
    Wilson DK; Rudolph FB; Quiocho FA
    Science; 1991 May; 252(5010):1278-84. PubMed ID: 1925539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bovine skeletal muscle adenosine deaminase: kinetic and thermodynamic studies.
    Martinez C; Zumalacárregui JM; Diez V
    Enzyme; 1988; 39(4):199-204. PubMed ID: 3391159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultramicrochemical studies on enzyme kinetics.
    Uitendaal MP; de Bruyn CH; Oei TL; Hösli P
    Adv Exp Med Biol; 1977; 76A():597-604. PubMed ID: 16450
    [No Abstract]   [Full Text] [Related]  

  • 39. Transition-state discrimination by adenosine deaminase from Aspergillus oryzae.
    Grosshans J; Wolfenden R
    Biochim Biophys Acta; 1993 Jan; 1161(1):28-32. PubMed ID: 8422418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate specificity of adenosine deaminase: the role of the substituents at the 2'- and 3'-carbons of adenine nucleosides, of their configuration and of the conformation of the furanose ring.
    Mikhailopulo IA; Wiedner H; Cramer F
    Biochem Pharmacol; 1981 May; 30(9):1001-4. PubMed ID: 7236309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.